Benitec Biopharma Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2025-11-14: Form 10-Q; Exhibit 10.4; Description Registration Rights Agreement, dated November 7, 2025, by and among Benitec Biopharma Inc., a Delaware corporation, Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd.*.
- 2025-11-07: Form 8-K; Exhibit 10.2; Description Placement Agency Agreement, dated November 5, 2025, by and between Benitec Biopharma Inc. and Leerink Partners LLC, TD Securities (USA) LLC and Evercore Group L.L.C..
- 2025-11-07: Form 8-K; Exhibit 10.1; Description Securities Purchase Agreement, dated November 5, 2025, by and between Benitec Biopharma Inc., Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd..
- 2025-05-14: Form 10-Q; Exhibit 10.5; Description Fifth Amendment to Lease, dated February 24, 2025, by and between Hayward Point Eden I Limited Partnership and Benitec Biopharma Inc.*.
| Filed | Form | Exhibit | Description |
|---|
| 2025-11-14 | 10-Q | 10.4 | Registration Rights Agreement, dated November 7, 2025, by and among Benitec Biopharma Inc., a Delaware corporation, Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd.* |
|---|
| 2025-11-07 | 8-K | 10.2 | Placement Agency Agreement, dated November 5, 2025, by and between Benitec Biopharma Inc. and Leerink Partners LLC, TD Securities (USA) LLC and Evercore Group L.L.C. |
|---|
| 2025-11-07 | 8-K | 10.1 | Securities Purchase Agreement, dated November 5, 2025, by and between Benitec Biopharma Inc., Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd. |
|---|
| 2025-05-14 | 10-Q | 10.5 | Fifth Amendment to Lease, dated February 24, 2025, by and between Hayward Point Eden I Limited Partnership and Benitec Biopharma Inc.* |
|---|
| 2025-05-14 | 10-Q | 10.4 | Fourth Amendment to Lease, dated August 30, 2021, by and between Hayward Point Eden I Limited Partnership and Benitec Biopharma Inc.* |
|---|
| 2025-03-27 | 8-K | 10.1 | Registration Rights Agreement, dated March 26, 2025, by and between Benitec Biopharma Inc., Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd. |
|---|
| 2025-03-26 | 8-K | 10.1 | Securities Purchase Agreement, dated March 25, 2025, by and between Benitec Biopharma Inc., Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd. |
|---|
| 2024-05-13 | 10-Q | 10.4 | Board Designation Agreement, dated April 22, 2024, by and between Benitec Biopharma Inc. and Suvretta Capital Management, LLC* |
|---|
| 2024-05-13 | 10-Q | 10.2 | Registration Rights Agreement, dated April 22, 2024, by and between Benitec Biopharma Inc. and each of the purchasers signatory thereto* |
|---|
| 2024-04-19 | 8-K | 10.4 | Form of Board Designation Agreement |
|---|
| 2024-04-19 | 8-K | 10.3 | Form of Voting Commitment Agreement |
|---|
| 2024-04-19 | 8-K | 10.2 | Form of Registration Rights Agreement |
|---|
| 2024-04-19 | 8-K | 10.1 | Securities Purchase Agreement, dated April 17, 2024, by and among Benitec Biopharma Inc. and each purchaser identified on the signature pages thereto |
|---|
| 2020-12-15 | 8-K | 10.2 | Form of Evidence of Award of Option Right Pursuant to the Benitec Biopharma Inc. 2020 Equity Incentive and Compensation Plan (Non-Employee Directors) |
|---|
| 2020-12-15 | 8-K | 10.1 | Form of Evidence of Award of Option Right Pursuant to the Benitec Biopharma Inc. 2020 Equity Incentive and Compensation Plan (Executives) |
|---|
| 2020-12-14 | 8-K | 10.1 | Benitec Biopharma Inc. 2020 Equity and Incentive Compensation Plan |
|---|